Allurion Technologies, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
Allurion Technologies, Inc. (ALUR) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $28.25 million as of 2023-06-30, per its 10-Q filed 2023-10-20.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2023-10-20
- 2023-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $28.25M.
- 2022-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $9.60M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value |
|---|---|
| 2023-06-30 | $28.25M 10-Q · filed 2023-10-20 |
| 2022-12-31 | $9.60M 10-Q · filed 2023-10-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |
| NEUROONE MEDICAL TECHNOLOGIES Corp (NMTC) | United States | $0.012B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B |